Skip to main content
Premium Trial:

Request an Annual Quote

Biomax Expands Agreement with Royal DSM to Include Synthetic Biology Solutions

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biomax Informatics today said that it has expanded its licensing and services agreement with Royal DSM to include solutions for synthetic biology using the BioXM Knowledge Management Environment system.

BioXM is a software platform for dynamic modeling, visualization, and analysis of biological and biomedical networks. It enables an agile process for the development of new life sciences applications and the quick deployment of new solutions to large user communities, Biomax said.

Biomax and Royal DSM have been collaborating since 1998, and Royal DSM had early access to the next-generation BioXM system. BioXM version 4 was released in March and has a customizable web portal builder that enables quick publishing of BioXM-based application on the Internet.

Based in Planegg, Germany, Biomax develops software solutions for life science applications. Royal DSM is a life science and materials science firm headquartered in Heerlen, the Netherlands.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.